Morgan Stanley (NYSE:MS) resumed coverage on Grifols SA (NASDAQ:GRFS) (GRF:SM) (OTC: GIFOF) shares, issuing an Overweight rating and establishing a price target of €12.00. The firm's analysts ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

The takeover deliberations come shortly after Grifols completed the sale of its 20% stake in Chinese blood products unit Shanghai RAAS to Haier, a deal first announced in 2020, raising cash of ...

Grifols’ share price previously fell more than 40% in January after the short-seller Gotham posted a report on January 9 claiming the Spanish blood-plasma products maker had manipulated its ...

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols ...

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in court.

First formed in 1909 and headquartered in Barcelona, Grifols is a manufacturer of plasma-based pharmaceuticals and other products like blood transfusion diagnostics, which is tax-domiciled in ...